The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEagle Eye Regulatory News (EYE)

Share Price Information for Eagle Eye (EYE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 490.00
Bid: 480.00
Ask: 500.00
Change: -15.00 (-2.97%)
Spread: 20.00 (4.167%)
Open: 505.00
High: 505.00
Low: 490.00
Prev. Close: 505.00
EYE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of share options

9 Apr 2021 16:33

RNS Number : 0391V
Eagle Eye Solutions Group PLC
09 April 2021
 

 

9 April 2021

 

Eagle Eye Solutions Group plc

("Eagle Eye", the "Group", or the "Company")

 

Issue of share options

 

Eagle Eye, a leading SaaS technology company that creates digital connections enabling personalised, real-time marketing through coupons, loyalty, apps, subscriptions and gift services, announces that the following options over ordinary shares of 1p each in Eagle Eye ("Ordinary Shares") were granted on 8 April 2021 to the following Executive Directors and person discharging managerial responsibilities ("PDMRs") of Eagle Eye for nil cost as follows:

 

Director/PDMR

Role

Number of Ordinary Shares subject to option grant

Total number of Ordinary Shares under option post grant

% of existing issued share capital

Tim Mason

CEO

142,662

1,729,908

6.6%

Steve Rothwell

CTO

82,412

831,759

3.2%

Lucy Sharman-Munday

CFO

82,412

662,480

2.5%

Al Henderson

CSO

37,876

304,041

1.2%

David Aylmer

COO

47,911

350,426

1.3%

 

These awards have been made under the Eagle Eye Group Solutions Plc Long Term Incentive Plan scheme with an exercise price of 1p per Ordinary Share and have been granted under the current year's Long Term Incentive Plan performance criteria, vesting following completion of the financial year ending 30 June 2023 subject to revenue and EBITDA performance criteria and the overall underlying performance of the Company. In common with previous awards, the number of options which vest will vary depending on the level of achievement between threshold, target and stretch performance levels.

Following the new grant of options and assuming all vesting criteria is met, the fully diluted number of Ordinary Shares would be 30,594,498; of which the total number of Ordinary Shares over which options currently issued and outstanding represent 14.7% of the fully diluted number of Ordinary Shares. This is in accordance with the Company's shareholder approved limit for shares outstanding under the Company's share option schemes at any time of a maximum of 20% of the ordinary share capital of the Company in issue at such time.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

 

Name

1. Tim Mason

2. Steve Rothwell

3. Lucy Sharman-Munday

4. Al Henderson

5. David Aylmer

2

Reason for the notification

a)

 

 

Position/status

1. Chief Executive Officer

2. Chief Technology Officer

3. Chief Financial Officer

4. Chief Sales Officer

5. Chief Operating Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eagle Eye Solutions Group plc

b)

LEI

2138002S1AIBVVMZ7A21

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 

 

Options over Ordinary shares of 1p each

 

GB00BKF1YD83

b)

Nature of transaction

Grant of Options

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

1. 142,662

2. 82,412

3. 82,412

4. 37,876

5. 47,911

Aggregated information

- Aggregated volume

- Price

 

Not applicable

e)

Date of the transaction

8 April 2021

f)

Place of the transaction

Outside of a trading venue

 

 

For further information, please contact:

 

Eagle Eye

Tim Mason, Chief Executive Officer

Lucy Sharman-Munday, Chief Financial Officer

 

 

Tel: 0844 824 3686

Investec (Nominated Advisor and Joint Broker)

Corporate Finance: David Anderson/ Sebastian Lawrence

Corporate Broking: Sara Hale/ Toba Fatimilehin

Tel: 020 7597 5970

 

Shore Capital (Joint Broker)

Corporate Finance: Hugh Morgan/ Daniel Bush/ Sarah Mather

Corporate Broking: Henry Willcocks

Tel: 020 7408 4090

Alma PR

Caroline Forde, Robyn Fisher, Molly Gretton

 

Tel: 020 3405 0205

 

About Eagle Eye

 

Eagle Eye is a leading SaaS technology company transforming marketing by creating digital connections that enable personalised performance marketing in real time through coupons, loyalty, apps, subscriptions and gift services. 

 

Eagle Eye AIR enables the secure issuance and redemption of digital offers and rewards at scale, across multiple channels, enabling a single customer view. We create a network between merchants, brands and audiences to enable customer acquisition, interaction and retention at lower cost whilst driving marketing innovation.

 

The Company's current customer base comprises leading names in UK Grocery, Retail, Leisure and Food & Beverage sectors, including Asda, Sainsbury's, Tesco, Waitrose and John Lewis & Partners, Virgin Red, JD Sports, Pret a Manger, Greggs, Mitchells & Butlers, Pizza Express; in North America, Loblaws, Shoppers Drug Mart and Southeastern Grocers and in Australia & New Zealand, Woolworths Group and The Warehouse Group.

 

 

For more information, please visit www.eagleeye.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKCBBPBKDCQK
Date   Source Headline
6th Nov 20187:00 amRNSHolding(s) in Company
22nd Oct 20189:30 amRNS2018 Annual Report & Accounts and Notice of AGM
18th Sep 20187:00 amRNSFinal Results
28th Aug 20187:00 amRNSNotice of Results
25th Jul 20187:00 amRNSTrading Update
28th Jun 20187:00 amRNSEagle Eye extends credit facility with Barclays
21st May 20187:00 amRNSDeath of a Director
10th May 20187:00 amRNSNew contract with Sainsbury's
11th Apr 201812:10 pmRNSDirector/PDMR Shareholding
4th Apr 20184:29 pmRNSDirector/PDMR Shareholding
13th Mar 201811:11 amRNSEagle Eye update on new Loblaw partner
13th Mar 20187:00 amRNSInterim Results
27th Feb 201812:00 pmRNSEagle Eye launches PC Optimum with Loblaw
5th Feb 20183:53 pmRNSIssue of Equity
23rd Jan 20187:00 amRNSTrading Update
19th Dec 20179:57 amRNSDirector Declaration
10th Nov 20174:03 pmRNSIssue of share options
9th Nov 20171:30 pmRNSResult of AGM
9th Nov 20177:00 amRNSAGM Statement
27th Oct 20174:56 pmRNSDirector/PDMR Shareholding
27th Oct 20179:58 amRNSDirector/PDMR Shareholding
12th Oct 20177:00 amRNS2017 Annual Report & Accounts and Notice of AGM
19th Sep 20176:14 pmRNSHolding(s) in Company
19th Sep 20177:00 amRNSFinal Results
16th Aug 20174:41 pmRNSNotice of Results
31st Jul 20177:00 amRNSNotification of Transactions by a Director/PDMR
31st Jul 20177:00 amRNSIssue of Equity
21st Jul 20176:06 pmRNSDirector/PDMR Shareholding
18th Jul 20172:07 pmRNSTrading Update - Replacement
18th Jul 20177:00 amRNSTrading Update
6th Jul 20177:00 amRNSEYE and TGCS sign renewed 2-year Asda contract
30th Jun 20173:26 pmRNSIssue of Equity
20th Jun 20177:00 amRNSIssue of Equity
12th Jun 201710:59 amRNSResult of General Meeting and Total Voting Rights
6th Jun 20179:33 amRNSIssue of Equity
1st Jun 201710:10 amRNSIssue of Equity
30th May 20179:55 amRNSIssue of Equity
26th May 20171:24 pmRNSUpdate on Placing
26th May 20171:03 pmRNSUpdate on Placing
26th May 20177:00 amRNSProposed Placing to raise up to £6.0 million
12th May 20177:00 amRNSEagle Eye signs 3 year contract with John Lewis
10th May 20177:00 amRNSAppointment of Chief Operating Officer
10th Apr 20177:00 amRNSIssue of Equity
7th Apr 201711:48 amRNSIssue of Equity
17th Mar 20173:15 pmRNSNotification of Transactions by a Director/PDMR
17th Mar 20173:06 pmRNSNotification of Transactions by a Director/PDMR
17th Mar 20172:50 pmRNSNotification of Transactions by a Director/PDMR
14th Mar 20177:02 amRNSEagle Eye and TCC Global in exclusive partnership
14th Mar 20177:00 amRNSInterim Results
21st Feb 20177:00 amRNSNotice of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.